hHv1 channels in neutrophils and the innate immune inflammatory response
中性粒细胞中的 hHv1 通道和先天免疫炎症反应
基本信息
- 批准号:10521974
- 负责人:
- 金额:$ 64.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-05 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcrosome ReactionAcuteAcute Lung InjuryAcute Respiratory Distress SyndromeAddressAffinityAirAlbuminsAnti-Inflammatory AgentsAutomobile DrivingBacteriaBacterial PneumoniaBindingBiophysicsBronchoalveolar Lavage FluidCOVID-19COVID-19 pandemicCellsCessation of lifeChronicComplexDataDevelopmentDiseaseEffectivenessElastasesFertilizationFluorescence Resonance Energy TransferFunctional disorderGenerationsGoalsGrantHealthHospitalizationHost DefenseHumanHypoxemiaImmuneImmunizationIn VitroInfectionInflammationInflammation MediatorsInflammatoryInflammatory ResponseInnate Immune SystemIschemic StrokeKnock-outKnockout MiceLeukocytesLifeLigandsLiquid substanceLungLung ComplianceMediatingMedicalMembraneMethodsMicroscopyModelingMorbidity - disease rateMusOocytesOxidantsOxidasesOxidesPathologyPathway interactionsPatientsPeptide HydrolasesPeptidesPhagocytesPharmaceutical PreparationsPharmacologyPharmacology StudyPharmacotherapyPhysiologyPneumoniaProductionProteinsProtonsPublic HealthPublishingReactive Oxygen SpeciesRegulationReportingResearchRespiratory BurstRoleSepsisSiteSpeedSperm CapacitationStructureVariantVentVirusWild Type MouseWorkbasechronic inflammatory diseasecombatcytokinedesignexperienceextracellularfungusimprovedin vivoinhibitorinnovationlung injurymortalitymouse modelneutrophilnovelnovel strategiesoperationpeptide Lpublic health relevancerational designresponsesingle moleculesperm cellstructural biologysuccesstoolvoltage
项目摘要
SUMMARY/ABSTRACT (30 lines)
Relevance to public health. Polymorphonuclear leukocytes (PMN, neutrophils) release reactive
oxygen species (ROS) to combat infection, but this inflammatory response can also initiate and propa-
gate lung damage. Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome
(ARDS) that is fatal in 40% of patients, are characterized by accumulation of albumin-rich fluid in the
pulmonary air spaces. Drug therapies focused on downstream cytokine actions have failed to improve
morbidity or mortality; we hypothesize, and offer evidence, that targeting the human voltage-gated pro-
ton channel (hHv1) at early steps can be more effective. We propose to target hHv1 because (i) the chan-
nel in PMN initiates and sustains the inflammatory response, (ii) C6, a unique blocker of hHv1 sup-
presses human PMN ROS production, and (iii) C6 suppresses lung compromise in an ALI mouse model.
Brief background. This application builds on advances in the last period when we created the first
high-affinity and specific direct blocker of hHv1 (C6 peptide) and used it to show, first, that human
sperm require hHv1-mediated H+ efflux to initiate capacitation, allowing the acrosomal reaction, and
oocyte fertilization and, second, that hHv1 in human PMN is required to produce and sustain release of
inflammatory agents, including ROS and proteases, during the innate immune inflammatory response.
Unique features and innovation. Our pilot data reveal a second target in the pathway: albumin
(Alb) is required to activate hHv1 in human PMN and we describe a peptide (L*) that blocks Alb-activa-
tion and ROS production. Supporting our driving hypothesis, we show here that both C6 and L* inhibit
hHv1 in human PMN, decreasing ROS production, and that C6 protects in an ALI mouse model, restor-
ing lung compliance, and decreasing ROS, proinflammatory cytokines, protein, and PMN in bron-
choalveolar lavage fluid. We employ our novel membrane tethered (T-peptide) method to speed struc-
ture-function studies and peptide design, show a bivalent C6 (C62) that fully inhibits open hHv1 chan-
nels, benefit from advanced biophysical and in vivo methods, and two expert collaborators.
Three specific aims. (1) Alb activation of hHv1 seeks the structural and mechanistic basis for the
action of Alb and a more potent natural metabolite. (2) Alb regulation of the PMN inflammatory re-
sponse seeks to delineate the role of hHv1 in PMN using C6, C62 and L* and the basis for peptide action.
(3) Inhibiting acute lung injury with Hv1 inhibitors studies an ALI model in WT and Hv1 KO mice.
Significance. This work addresses an unmet medical need, recently made more apparent by the ad-
vent of COVID-19-related ALI/ARDS and has broader influence because Hv1 in PMN and other phago-
cytes is complicit in additional acute and chronic inflammatory disorders. We propose to apply unique
hHv1 inhibitors and innovative methods to understand and suppress this pathophysiology.
概要/摘要(30行)
与公共卫生的相关性。多形性白细胞(PMN,中性粒细胞)释放反应性
氧自由基(ROS)对抗感染,但这种炎症反应也可以启动和促进,
门肺损伤急性肺损伤(ALI)及其严重形式,急性呼吸窘迫综合征
在40%的患者中是致命的急性呼吸窘迫综合征(ARDS)的特征是在肺组织中积聚富含白蛋白的液体。
肺气隙专注于下游细胞因子作用的药物治疗未能改善
发病率或死亡率;我们假设,并提供证据,针对人类电压门控蛋白,
吨通道(hHv 1)在早期步骤可以更有效。我们建议以hHv 1为目标,因为(i)改变-
中性粒细胞中的nel启动并维持炎症反应,(ii)C6,一种独特的hHv 1抑制剂,
抑制人PMN ROS产生,和(iii)C6抑制ALI小鼠模型中的肺损害。
简要背景。这个应用程序建立在我们创建第一个
hHv 1(C6肽)高亲和力和特异性直接阻断剂,并使用它来显示,首先,人
精子需要hHv 1介导的H+流出来启动获能,允许顶体反应,
卵母细胞受精,第二,人PMN中的hHv 1是产生和维持
在先天性免疫炎症反应期间,炎症因子,包括ROS和蛋白酶。
独特的功能和创新。我们的试验数据揭示了途径中的第二个靶点:白蛋白
(Alb)是激活人PMN中的hHv 1所必需的,我们描述了一种肽(L*),其阻断ALB-激活-
和ROS的产生。支持我们的驱动假说,我们在这里表明,C6和L* 抑制,
人PMN中的hHv 1,减少ROS的产生,C6在ALI小鼠模型中保护,
肺顺应性,并减少ROS,促炎细胞因子,蛋白质,和中性粒细胞在肺,
肺泡灌洗液。我们采用我们的新的膜栓系(T肽)的方法,以加快结构,
功能研究和肽设计显示,二价C6(C62)完全抑制开放的hHv 1变异,
nels,受益于先进的生物物理和体内方法,以及两位专家合作者。
三个具体目标。(1)Alb对hHv 1的激活作用是为了寻找这种作用的结构和机制基础。
Alb和更有效的天然代谢物的作用。(2)白蛋白对中性粒细胞炎症反应的调节
sponse试图用C6、C62和L* 以及肽作用的基础来描述hHv 1在PMN中的作用。
(3)用Hv 1抑制剂抑制急性肺损伤研究WT和Hv 1 KO小鼠的ALI模型。
意义这项工作解决了一个未满足的医疗需求,最近更明显的广告-
COVID-19相关的ALI/ARDS的排放,并具有更广泛的影响,因为PMN和其他噬菌体中的Hv 1,
细胞参与其它急性和慢性炎性疾病。我们建议采用独特的
hHv 1抑制剂和创新的方法来理解和抑制这种病理生理学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steve A N Goldstein其他文献
Steve A N Goldstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steve A N Goldstein', 18)}}的其他基金
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 64.23万 - 项目类别:
hHv1 channels in neutrophils and the innate immune inflammatory response
中性粒细胞中的 hHv1 通道和先天免疫炎症反应
- 批准号:
10677676 - 财政年份:2022
- 资助金额:
$ 64.23万 - 项目类别:
Channels with KCNE Subunits: Conformational Dynamics
具有 KCNE 子单元的通道:构象动力学
- 批准号:
8582069 - 财政年份:2011
- 资助金额:
$ 64.23万 - 项目类别:
Channels with KCNE Subunits: Conformational Dynamics
具有 KCNE 子单元的通道:构象动力学
- 批准号:
8301562 - 财政年份:2011
- 资助金额:
$ 64.23万 - 项目类别:
Channels with KCNE Subunits: Conformational Dynamics
具有 KCNE 子单元的通道:构象动力学
- 批准号:
8384965 - 财政年份:2011
- 资助金额:
$ 64.23万 - 项目类别:
Core D5: Phage display synthetic toxin pipeline
核心D5:噬菌体展示合成毒素管道
- 批准号:
7922839 - 财政年份:2010
- 资助金额:
$ 64.23万 - 项目类别:
A New Family of Voltage-gated Potassium Channel Regulaory Subunits
电压门控钾通道调节亚基的新家族
- 批准号:
8413639 - 财政年份:2007
- 资助金额:
$ 64.23万 - 项目类别:
相似海外基金
Studies on the culture of male germ cells and induction of sperm acrosome reaction using hollow microcapsules.
空心微胶囊培养雄性生殖细胞及诱导精子顶体反应的研究。
- 批准号:
20K09584 - 财政年份:2020
- 资助金额:
$ 64.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Membrane raft-mediated mechanism of sperm acrosome reaction in avian sperm
膜筏介导的禽精子顶体反应机制
- 批准号:
17KK0150 - 财政年份:2018
- 资助金额:
$ 64.23万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research)
The acrosome reaction in sperm: A special type of regulated exocytosis
精子顶体反应:一种特殊类型的调节胞吐作用
- 批准号:
170440292 - 财政年份:2010
- 资助金额:
$ 64.23万 - 项目类别:
Research Grants
Cross-talk of Ca^2+ signal on acrosome reaction in starfish
海星顶体反应中 Ca^2 信号的串扰
- 批准号:
19570074 - 财政年份:2007
- 资助金额:
$ 64.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of sperm acrosome reaction
精子顶体反应的调节
- 批准号:
203132-2002 - 财政年份:2006
- 资助金额:
$ 64.23万 - 项目类别:
Discovery Grants Program - Group
Role of Phosphatidic Acid in the Sperm Acrosome Reaction
磷脂酸在精子顶体反应中的作用
- 批准号:
7072440 - 财政年份:2006
- 资助金额:
$ 64.23万 - 项目类别:
Regulation of sperm acrosome reaction
精子顶体反应的调节
- 批准号:
203132-2002 - 财政年份:2005
- 资助金额:
$ 64.23万 - 项目类别:
Discovery Grants Program - Group